scholarly article | Q13442814 |
P356 | DOI | 10.1016/0042-6822(86)90388-0 |
P698 | PubMed publication ID | 3012869 |
P2093 | author name string | Collins PL | |
Olmsted RA | |||
Venkatesan S | |||
Coligan JE | |||
Spriggs MK | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human parainfluenza | Q2051533 |
P304 | page(s) | 241-251 | |
P577 | publication date | 1986-07-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses | |
P478 | volume | 152 |
Q37124759 | A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice |
Q36781736 | Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. |
Q36780319 | Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. |
Q41853385 | Antigenic and genetic variability of human metapneumoviruses |
Q24615805 | Biology of parainfluenza viruses |
Q41633876 | Budding site of sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice |
Q40108142 | Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3. |
Q37113787 | Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge |
Q34095297 | Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity. |
Q36288046 | Conservation of delta-crystallin gene structure between ducks and chickens |
Q28324290 | Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins |
Q28318487 | Effects of protease inhibitors on replication of various myxoviruses |
Q41651270 | Evolution of the fusion protein gene of human parainfluenza virus 3 |
Q36467244 | Expression at the cell surface of native fusion protein of the Newcastle disease virus (NDV) strain Italien from cloned cDNA. |
Q36919535 | Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity |
Q37401975 | Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity |
Q36884312 | Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice |
Q66678731 | Furin-mediated protein processing in infectious diseases and cancer |
Q45833140 | Fusion (F) protein gene of Newcastle disease virus: sequence and hydrophobicity comparative analysis between virulent and avirulent strains |
Q38334591 | Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. |
Q40064981 | Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis |
Q45787436 | Human parainfluenza virus type 3: Analysis of the cytoplasmic tail and transmembrane anchor of the hemagglutinin-neuraminidase protein in promoting cell fusion |
Q36867365 | Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map |
Q36830350 | Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein |
Q40131073 | Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization |
Q36866184 | Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection |
Q59071163 | Leucine zipper motif extends |
Q45859746 | Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein |
Q36802607 | Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites |
Q40566088 | Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins |
Q40566093 | Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins. |
Q37730457 | Paramyxoviridae: transcription and replication |
Q45863269 | Pneumotropic revenants derived from a pantropic mutant, F1-R, of sendai virus |
Q30364344 | Polar profile of antiviral peptides from AVPpred Database. |
Q36780345 | Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus |
Q36797439 | Properties of human parainfluenza virus type 3 RNA polymerase/replicase activity in vitro: consensus with other negative-stranded RNA viruses |
Q40040358 | Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. |
Q36826673 | Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus |
Q36548529 | Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse |
Q33558419 | Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice |
Q48343811 | Sequence analysis of the nucleocapsid and phosphoprotein genes of avian pneumoviruses circulating in the US. |
Q91990228 | Sequencing and analysis of globally obtained human parainfluenza viruses 1 and 3 genomes |
Q33932954 | Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion |
Q36827291 | The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species |
Q34337480 | The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins |
Q35000616 | The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction |
Q30328490 | The pathogenesis of influenza in humans. |
Q36001197 | The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein |
Q40686662 | Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding |
Q36165039 | tRNA(Trp) translation of leader peptide codon 12 and other factors that regulate expression of the tryptophanase operon |
Search more.